Colon-26 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Mouse cell lines

Organism

Mouse

Donor History

Carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 x 10⁴ cells/cm² will yield in a confluent layer in about 4 days. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/Colon-26-Cells/400156

SKU: 400156 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The Colon-26 cell line, derived from a murine adenocarcinoma, was established following the induction of colon carcinoma in a BALB/c female mouse using N-Nitroso-N-methylurethane (NMU). This particular carcinogen was administered rectally, a method that efficiently models the initiation of colorectal cancer. The establishment of the Colon-26 cell line was first reported by Corbett et al. in 1975, marking a significant development in the study of carcinogen-induced cancers in animal models.
Colon-26 cells are transplantable and maintain the adenocarcinoma characteristics of the original tumor, making them a valuable tool for oncological research, especially in studies related to colorectal cancer. The cell line is particularly useful for examining the efficacy of anti-cancer therapies and the molecular pathways involved in colorectal cancer progression. Due to its origin in BALB/c mice, the Colon-26 cell line is also frequently used in immunologically relevant research, providing insights into the interaction between cancer growth and the immune response in a syngeneic host.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.